NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ), a leading biotechnology company specializing in gene identification and genetic and immune regulation technologies for diagnostic and therapeutic applications, announced today that Barry Weiner, President, will make a presentation at the Lazard Capital Markets Fourth Annual Healthcare Conference on Wednesday, November 28, 2007, at 2:00 PM (E.T.) at The New York Palace Hotel in New York City.
